Complexes of Carboxylated Terpyridines and Dipyrazinylpyridines
H), 8.74 (d, 2 H), 8.76 (s, 2 H) ppm. 13C NMR (CDCl3): δ = 14.3, 140.0, 146.0, 147.3, 148.0, 149.0, 153.6, 154.6, 167.4 ppm.
61.1, 118.9, 121.7, 124.0, 127.3, 130.1, 130.8, 136.9, 142.8, 149.1,
C40H26F12N10O4P2Ru (1101.70): calcd. C 43.61, H 2.38, N 12.71;
149.1, 155.9, 156.1, 166.2 ppm. C24H19N3O2 (381.43): calcd. C found C 43.82, H 2.13, N 12.25. LDI-MS: m/z (%) = 810.87 (100),
75.72, H 5.02, N 11.02; found C 75.72, H 5.18, N 10.90. EI-MS:
766.90 (100), 722.92 (38). IR: ν = 1707 (C=O), 3434 (O–H str.),
˜
m/z (%) = 381 (100), 352 (12), 336 (21), 308 (29). IR: ν = 1690
837 (PF6) cm–1.
˜
(C=O str.) cm–1.
[Bis(4-carboxy-2,6-dipyrazin-2-ylpyridine)]ruthenium(II) Bis(hexa-
fluorophosphate) [Ru(H4)2](PF2)6: This was produced in the same
manner as was used to obtain bis(4Ј-carboxy-2,2Ј:6Ј,2ЈЈ-terpyrid-
ine)ruthenium(II) bis(hexafluorophosphate),[5] by hydrolysis of
[Ru(Et4)2](PF6)2 (0.171 mg, 0.17 mmol) to produce a red powder
1
Ester Et3: H NMR (CDCl3): δ = 1.37 (t, 3 H), 4.41 (q, 2 H), 7.93
(d, 2 H), 8.21 (d, 2 H), 8.65 (br. s, 2 H), 8.69 (br. s, 2 H), 8.75 (s,
2 H), 9.88 (br. s, 2 H) ppm. 13C NMR (CDCl3): δ = 14.3, 61.3,
119.9, 127.2, 130.3, 131.3, 142.0, 143.6, 144.9, 149.7, 150.5, 154.6,
166.1 ppm. C22H17N5O2 (383.40): calcd. C 68.92, H 4.47, N 18.27;
found C 69.09, H 4.62, N 17.95. EI-MS: m/z (%) = 383.27 (27),
1
(293 mg, 38%). H NMR (CD3CN): δ = 7.47 (d, 4 H), 8.41 (d, 4
H), 9.43 (s, 4 H), 9.80 (br. s, 4 H) ppm. 13C NMR ([D6]dmso): δ =
124.7, 139.5, 145.8, 148.0, 148.7, 152.9, 154.7, 165.7 ppm.
C28H18F12N10O4P2Ru (949.51): calcd. C 35.42, H 1.91, N 14.75;
found C 35.22, H 2.22, N 14.42. LDI-MS: m/z (%) = 803.14 (50),
338.27 (5), 284.21 (16.9). IR: ν = 1726 (C=O str.) cm–1.
˜
Ruthenium Complexes
Bis[4Ј-(4-Carboxyphenyl)-2,2Ј:6Ј,2ЈЈ-terpyridine]ruthenium(II) Bis-
(hexafluorophosphate) [Ru(H1)2](PF6)2: RuCl3·3H2O (147 mg,
0.56 mmol) and AgBF4 (330 mg, 1.69 mmol) were dissolved in dmf
(30 mL), and the mixture was kept at reflux for 3 h until a sand-
coloured suspension appeared and the solution had turned bright
red. Upon addition of ligand H1 (400 mg, 1.13 mmol), the mixture
turned black, at which point more dmf (5 mL) was added, and
reflux was maintained for 3 d, yielding a red solution. This was
filtered through Celite, and the filtrate was treated with 0.5 aque-
ous NH4PF6 (18 mL) and allowed to stand at ambient temperature
overnight. The red precipitate was isolated by filtration through
Celite, rinsed several times with water and twice with diethyl ether,
and finally collected with hot CH3CN containing a few drops of
aqueous HPF6 (60% tech. grade solution). The solution was con-
centrated, and a red microcrystalline product was obtained after
the addition of diethyl ether (590 mg, 95%). 1H NMR ([D6]dmso):
δ = 7.28 (dd, 4 H), 7.56 (d, 4 H), 7.98 (dd, 4 H), 8.29 (d, 4 H), 8.55
(d, 4 H), 9.14 (d, 4 H), 9.54 (s, 4 H) ppm. 13C NMR ([D6]dmso):
δ = 121.9, 125.3, 128.2, 128.3, 130.6, 132.5, 138.5, 140.6, 146.1,
152.7, 155.6, 158.3, 167.3 ppm. C44H30F12N6O4P2Ru (1097.75):
calcd. C 48.14, H 2.75, N 7.66; found C 47.53, H 2.70, N 7.45.
LDI-MS: m/z (%) = 1097.34 (13), 808.17 (23), 763.17 (32), 718.18
587.06 (40), 570.07 (95). IR: ν = 1712 (C=O str.), 838 (P–F str.)
˜
cm–1.
Bis[4Ј-(4-ethoxycarbonylphenyl)-2,2Ј:6Ј,2ЈЈ-terpyridine]ruthenium(II)
Bis(hexafluorophosphate) [Ru(Et1)2](PF6)2: By following the same
procedure used for [Ru(H1)2](PF6)2, but without the use of HPF6,
RuCl3·3H2O (172 mg, 0.655 mmol), AgBF4 (383 mg, 1.97 mmol)
and ligand Et1 (500 mg, 1.13 mmol) were converted to complex
1
[Ru(Et1)2](PF6)2, a red microcrystalline product (0.74 g, 98%). H
NMR (CD3CN): δ = 1.48 (t, 6 H), 4.48 (q, 4 H), 7.22 (dd, 4 H),
7.46 (d, 4 H), 7.99 (t, 4 H), 8.33 (d, 4 H), 8.40 (d, 4 H), 8.68 (d, 4
H), 9.07 (s, 4 H) ppm. 13C NMR (CD3CN): δ = 13.6, 61.3, 121.9,
124.6, 127.5, 128.0, 130.3, 132.1, 138.1, 141.0, 147.0, 152.5, 155.5,
158.0, 165.7 ppm. C48H38F12N6O4P2Ru (1153.86): calcd. C 49.96,
H 3.32, N 7.28; found C 49.54, H 3.30, N 6.99. LDI-MS: m/z (%)
= 1153.28 (13), 863.22 (22), 835.18 (12), 807.16 (80). IR: ν = 1712
˜
(C=O str.), 838 (P–F str.) cm–1.
Bis(4Ј-ethoxycarbonyl-2,2Ј:6Ј,2ЈЈ-terpyridine)ruthenium(II) Bis-
(hexafluorophosphate) [Ru(Et2)2](PF6)2: As for [Ru(Et1)2](PF6)2,
RuCl3·3H2O (85 mg, 0.325 mmol), AgBF4 (191 mg, 0.98 mmol)
and ligand Et2 (200 mg, 0.655 mmol) were converted to [Ru(Et2)2]-
(PF6)2, also a red microcrystalline product (269 mg, 82%). 1H
NMR (CD3CN): δ = 1.59 (t, 3 H), 4.68 (q, 2 H), 7.21 (dd, 4 H),
7.37 (d, 4 H), 7.98 (dd, 4 H), 8.69 (d, 4 H), 9.24 (s, 4 H) ppm. 13C
NMR (CD3CN): δ = 13.6, 62.9, 122.8, 125.0, 127.8, 138.4, 138.4,
152.5, 155.7, 157.3, 164.8 ppm. C36H30F12N6O4P2Ru (1001.67):
calcd. C 43.17, H 3.02, N 8.39; found C 43.20, H 3.08, N 8.42.
LDI-MS: m/z (%) = 782.83 (100), 711.83 (100), 684.86 (43), 639.85
(61). IR: ν = 1713 (C=O str.), 3431 (O–H str.), 842 (P–F str.) cm–1.
˜
Bis(4Ј-carboxy-2,2Ј:6Ј,2ЈЈ-terpyridine)ruthenium(II) Bis(hexafluoro-
phosphate) [Ru(H2)2](PF6)2: Complex [Ru(Et2)2](PF6)2 (0.17 mg,
0.17 mmol) was suspended in water (20 mL) to which 0.1 NaOH
(6 mL) was added. The suspension was heated to reflux for 1.5 d.
The resulting red solution was concentrated to remove EtOH, then
water (4 mL) was added, and the solution was acidified to pH = 2
by addition of 1 perchloric acid or HCl, resulting in the immedi-
ate formation of a precipitate. This was collected by vacuum fil-
tration, then washed with cold water and copiously with diethyl
ether to give the pure product as a red powder in 100% yield
(100), 611.95 (98), 566.88 (86). IR: ν = 1727 (C=O str.), 843 (P–F
˜
str.) cm–1.
{Bis[4-(4-ethoxycarbonylphenyl)-2,6-dipyrazin-2-ylpyridine]}-
ruthenium(II) Bis(hexafluorophosphate) [Ru(Et3)2](PF2)6:
RuCl3·3H2O (137 mg, 0.52 mmol), AgBF4 (305 mg, 1.56 mmol)
and Et3 (400 mg, 1.04 mmol) were used by following the same pro-
cedure as with ligand H3. The crude, dark red-brown hexafluoro-
phosphate salt was purified by preparatory TLC on 2 mm-thick
Macherey–Nagel Polygram Sil G/UV silica gel plates, developed
with CH3CN/saturated KNO3/H2O (65:2:1). The most mobile red
band was scraped off and extracted with CH3CN and CH3OH. The
solvents were evaporated in vacuo. The resulting dark red solid was
dissolved in a minimum amount of CH3CN and poured into a
saturated aqueous solution of NH4PF6. The mixture was allowed
to stand at ambient temperature overnight to give a red precipitate,
1
(160 mg). H NMR ([D6]dmso): δ = 7.19 (dd, 4 H), 7.36 (d, 4 H),
7.96 (dd, 4 H), 8.67 (d, 4 H), 9.25 (s, 4 H) ppm. 13C NMR ([D6]-
dmso): δ = 123.7, 125.6, 128.4, 138.2, 138.8, 152.7, 155.5, 157.6,
165.9 ppm. C32H22F12N6O4P2Ru (945.56): calcd. C 40.65, H 2.35,
N 8.89; found C 40.09, H 2.38, N 9.17. LDI-MS: m/z (%) = 800.18
(20), 798.17 (80), 583.08 (70), 566.09 (80). IR: ν = 1694 (C=O str.),
˜
3447 (O–H str.) cm–1.
{Bis[4-(4-carboxyphenyl)-2,6-dipyrazin-2-ylpyridine]}ruthenium(II)
Bis(hexafluorophosphate) [Ru(H3)2](PF2)6: Analogously to 4Ј-(4-
carboxyphenyl)-2,2Ј:6Ј,2ЈЈ-terpyridine,[5] RuCl3·3H2O (73 mg,
0.29 mmol), AgBF4 (163 mg, 0.837 mmol) and ligand H3 (200 mg, which was isolated by vacuum filtration through a Celite layer and
0.563 mmol) were used to obtain a dark red microcrystalline prod-
washed with cold water and copiously with diethyl ether (180 mg,
uct (307 mg, 58%). 1H NMR ([D6]dmso): δ = 7.74 (br. s, 4 H), 8.34 30%). 1H NMR (CD3CN): δ = 1.48 (t, 6 H), 4.49 (q, 4 H), 7.56 (s,
(d, 4 H), 8.49 (br. s, 4 H), 8.57 (d, 4 H), 9.72 (s, 4 H), 10.2 (br. s, 4 H), 8.37 (d, 4 H), 8.42 (br. s, 4 H), 8.44 (d, 4 H), 9.25 (s, 4 H),
4 H) ppm. 13C NMR ([D6]dmso): δ = 122.5, 128.4, 130.7, 133.0,
9.80 (br. s, 4 H) ppm. 13C NMR (CD3CN): δ = 13.6, 61.4, 123.0,
Eur. J. Inorg. Chem. 2010, 3040–3050
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
3049